Glaxosmithkline Pharmaceuticals informs about compliance certificate

04 Jul 2024 Evaluate
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Glaxosmithkline Pharmaceuticals has informed that it enclosed a copy of the Certificate received from Kfin Technologies, the Registrar and share Transfer Agent of the Company, for the quarter ended 30th June 2024.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2311.50 -68.35 (-2.87%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×